Fig. 4

Two hypothesized pathogenetic mechanisms underlying the presence of pS6-positive DNs in FCD II include: (1) activation of the upstream mTOR pathway, and (2) involvement of inflammatory processes
Two hypothesized pathogenetic mechanisms underlying the presence of pS6-positive DNs in FCD II include: (1) activation of the upstream mTOR pathway, and (2) involvement of inflammatory processes